Dissecting the molecular pathophysiology of drug-induced liver injury

Area of Science:

• Hepatology and Gastroenterology
• Toxicology
• Immunology

Background:

• Drug-induced liver injury (DILI) is a significant clinical challenge with diverse presentations.
• Understanding DILI pathogenesis is crucial for effective patient management.
• Recent advancements in preclinical models offer new insights into liver damage mechanisms.

Purpose of the Study:

• To review the pathophysiological mechanisms underlying drug-induced liver injury.
• To elucidate the roles of direct drug toxicity and immune responses in DILI.
• To explore the association between hepatocyte death pathways and signaling in DILI.

Main Methods:

• Review of current literature on DILI mechanisms.
• Analysis of preclinical models for understanding drug toxicity.
• Examination of molecular pathways involved in hepatocellular damage and immune responses.

Main Results:

• DILI involves direct hepatotoxicity, often via reactive oxygen species and mitochondrial dysfunction (e.g., acetaminophen).
• Innate and adaptive immune responses are critical in idiosyncratic DILI.
• Specific signaling pathways are linked to various forms of hepatocyte death.

Conclusions:

• Drug toxicity and immune-mediated pathways are central to DILI pathogenesis.
• Further research into these mechanisms can guide therapeutic strategies for DILI.
• Understanding hepatocyte death pathways is essential for predicting and treating DILI.